Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability. [electronic resource]
Producer: 20190326Description: 59-76 p. digitalISSN:- 1768-3254
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Binding Sites
- Bortezomib -- therapeutic use
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cyclooxygenase 1 -- chemistry
- Cyclooxygenase 2 -- metabolism
- Cyclooxygenase Inhibitors -- chemistry
- Humans
- Isoxazoles -- chemistry
- Multiple Myeloma -- drug therapy
- Platelet Aggregation Inhibitors -- pharmacology
- Protein Binding
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.